Attovia Therapeutics (ATTO) Revenue & Revenue Breakdown
Attovia Therapeutics Revenue Highlights
Latest Revenue (Y)
$1.35M
Latest Revenue (Q)
$450.00K
Attovia Therapeutics Revenue by Period
Attovia Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $1.35M | 100.00% |
| 2024-12-31 | - | - |
Attovia Therapeutics generated $1.35M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Attovia Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $450.00K | 100.00% |
| 2026-03-31 | - | 100.00% |
| 2025-03-31 | - | - |
Attovia Therapeutics generated $450.00K in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Attovia Therapeutics Revenue Breakdown
Attovia Therapeutics Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 26 |
|---|---|
| Collaboration Revenue | $450.00K |
Latest
Attovia Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Collaboration Revenue (100.00%).
Attovia Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ANAB | AnaptysBio | $234.60M | $25.56M |
| ALMS | Alumis | $24.05M | $1.66M |
| EVMN | Evommune | $13.00M | - |
| ACRS | Aclaris Therapeutics | $7.83M | $1.63M |
| ATTO | Attovia Therapeutics | $1.35M | $450.00K |
| ORKA | Oruka Therapeutics | - | - |
| AGMB | AgomAb Therapeutics N.V. American Depositary Shares | - | - |
| ZURA | Zura Bio | - | - |
| MLTX | MoonLake Immunotherapeutics | - | - |
| CNTB | Connect Biopharma | - | - |
| QTTB | Q32 Bio | - | - |